Drug recall
Red Blood Cells (Apheresis) Leukocytes Reduced
FDA recall event 63012 · Class II · New York Blood Center, Inc.
Key facts
| Event ID | 63012 |
|---|---|
| Recall numbers | B-0035-13 |
| Recalling firm | New York Blood Center, Inc. |
| Product type | Biologics |
| Products | Red Blood Cells (Apheresis) Leukocytes Reduced |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Blood products, for which quality control and distribution of products did not meet specifications, were distributed. |
| Initiation date | Jul 27, 2012 |
| Report date | Oct 10, 2012 |
| Termination date | Oct 1, 2012 |
| City | Westbury |
| State | NY |
| Country | United States |
| FEI number | 2470902 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: